Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/114842
Title: Predictive medicine: outcomes, challenges and opportunities in the Synergy-COPD project
Author: Miralles, Felip
Gomez Cabrero, David
Lluch Ariet, Magí
Tegnér, Jesper
Cascante i Serratosa, Marta
Roca Torrent, Josep
Synergy‐COPD consortium
Keywords: Malalties cròniques
Malalties pulmonars obstructives cròniques
Comorbiditat
Telecomunicació en medicina
Investigació mèdica
Medicina preventiva
Chronic diseases
Chronic obstructive pulmonary diseases
Comorbidity
Telecommunication in medicine
Medicine research
Preventive medicine
Issue Date: 28-Nov-2014
Publisher: BioMed Central
Abstract: BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is a major challenge for healthcare. Heterogeneities in clinical manifestations and in disease progression are relevant traits in COPD with impact on patient management and prognosis. It is hypothesized that COPD heterogeneity results from the interplay of mechanisms governing three conceptually different phenomena: 1) pulmonary disease, 2) systemic effects of COPD and 3) co-morbidity clustering. OBJECTIVES: To assess the potential of systems medicine to better understand non-pulmonary determinants of COPD heterogeneity. To transfer acquired knowledge to healthcare enhancing subject-specific health risk assessment and stratification to improve management of chronic patients. METHOD: Underlying mechanisms of skeletal muscle dysfunction and of co-morbidity clustering in COPD patients were explored with strategies combining deterministic modelling and network medicine analyses using the Biobridge dataset. An independent data driven analysis of co-morbidity clustering examining associated genes and pathways was done (ICD9-CM data from Medicare, 13 million people). A targeted network analysis using the two studies: skeletal muscle dysfunction and co-morbidity clustering explored shared pathways between them. RESULTS: (1) Evidence of abnormal regulation of pivotal skeletal muscle biological pathways and increased risk for co-morbidity clustering was observed in COPD; (2) shared abnormal pathway regulation between skeletal muscle dysfunction and co-morbidity clustering; and, (3) technological achievements of the projects were: (i) COPD Knowledge Base; (ii) novel modelling approaches; (iii) Simulation Environment; and, (iv) three layers of Clinical Decision Support Systems. CONCLUSIONS: The project demonstrated the high potential of a systems medicine approach to address COPD heterogeneity. Limiting factors for the project development were identified. They were relevant to shape strategies fostering 4P Medicine for chronic patients. The concept of Digital Health Framework and the proposed roadmap for its deployment constituted relevant project outcomes.
Note: Reproducció del document publicat a: https://doi.org/10.1186/1479-5876-12-S2-S12
It is part of: Journal of Translational Medicine, 2014, vol. 12, num. Suppl 2, p. S12
URI: http://hdl.handle.net/2445/114842
Related resource: https://doi.org/10.1186/1479-5876-12-S2-S12
ISSN: 1479-5876
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
648315.pdf297.25 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons